192 related articles for article (PubMed ID: 26123090)
1. Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma.
van Dijk EH; van Herpen CM; Marinkovic M; Haanen JB; Amundson D; Luyten GP; Jager MJ; Kapiteijn EH; Keunen JE; Adamus G; Boon CJ
Ophthalmology; 2015 Sep; 122(9):1907-16. PubMed ID: 26123090
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy.
Francis JH; Canestraro J; Haggag-Lindgren D; Harding JJ; Diamond EL; Drilon A; Li BT; Iyer G; Schram AM; Abramson DH
Ophthalmol Retina; 2021 Dec; 5(12):1187-1195. PubMed ID: 34102344
[TBL] [Abstract][Full Text] [Related]
3. Study of subretinal exudation and consequent changes in acute central serous chorioretinopathy by optical coherence tomography.
Yu J; Jiang C; Xu G
Am J Ophthalmol; 2014 Oct; 158(4):752-756.e2. PubMed ID: 24973608
[TBL] [Abstract][Full Text] [Related]
4. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.
Fujimoto H; Gomi F; Wakabayashi T; Sawa M; Tsujikawa M; Tano Y
Ophthalmology; 2008 Sep; 115(9):1494-500, 1500.e1-2. PubMed ID: 18394706
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial retinal dystrophy associated with the m.3243A>G mutation.
de Laat P; Smeitink JAM; Janssen MCH; Keunen JEE; Boon CJF
Ophthalmology; 2013 Dec; 120(12):2684-2696. PubMed ID: 23806424
[TBL] [Abstract][Full Text] [Related]
6. Near-infrared fundus autofluorescence in subclinical best vitelliform macular dystrophy.
Parodi MB; Iacono P; Del Turco C; Bandello F
Am J Ophthalmol; 2014 Dec; 158(6):1247-1252.e2. PubMed ID: 25174897
[TBL] [Abstract][Full Text] [Related]
7. Transient MEK inhibitor-associated retinopathy in metastatic melanoma.
Urner-Bloch U; Urner M; Stieger P; Galliker N; Winterton N; Zubel A; Moutouh-de Parseval L; Dummer R; Goldinger SM
Ann Oncol; 2014 Jul; 25(7):1437-1441. PubMed ID: 24864047
[TBL] [Abstract][Full Text] [Related]
8. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options.
Boon CJ; van den Born LI; Visser L; Keunen JE; Bergen AA; Booij JC; Riemslag FC; Florijn RJ; van Schooneveld MJ
Ophthalmology; 2013 Apr; 120(4):809-20. PubMed ID: 23290749
[TBL] [Abstract][Full Text] [Related]
9. Dominant cystoid macular dystrophy.
Saksens NT; van Huet RA; van Lith-Verhoeven JJ; den Hollander AI; Hoyng CB; Boon CJ
Ophthalmology; 2015 Jan; 122(1):180-91. PubMed ID: 25267528
[TBL] [Abstract][Full Text] [Related]
10. Nondamaging photothermal therapy for the retina: initial clinical experience with chronic central serous retinopathy.
Lavinsky D; Palanker D
Retina; 2015 Feb; 35(2):213-22. PubMed ID: 25158944
[TBL] [Abstract][Full Text] [Related]
11. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography.
Song IS; Shin YU; Lee BR
Am J Ophthalmol; 2012 Aug; 154(2):366-375.e4. PubMed ID: 22633348
[TBL] [Abstract][Full Text] [Related]
12. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
[TBL] [Abstract][Full Text] [Related]
13. Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy.
Pang CE; Shah VP; Sarraf D; Freund KB
Am J Ophthalmol; 2014 Aug; 158(2):362-371.e2. PubMed ID: 24794091
[TBL] [Abstract][Full Text] [Related]
14. Clinical and immunological characterization of paraneoplastic retinopathy.
Makiyama Y; Kikuchi T; Otani A; Oishi A; Guo C; Nakagawa S; Ogino K; Kojima H; Kurimoto M; Yoshimura N
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5424-31. PubMed ID: 23860756
[TBL] [Abstract][Full Text] [Related]
15. Correlation between fundus autofluorescence and central visual function in chronic central serous chorioretinopathy.
Eandi CM; Piccolino FC; Alovisi C; Tridico F; Giacomello D; Grignolo FM
Am J Ophthalmol; 2015 Apr; 159(4):652-8. PubMed ID: 25555802
[TBL] [Abstract][Full Text] [Related]
16. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomographic assessment of diabetic macular edema: comparison with fluorescein angiographic and clinical findings.
Ozdek SC; Erdinç MA; Gürelik G; Aydin B; Bahçeci U; Hasanreisoğlu B
Ophthalmologica; 2005; 219(2):86-92. PubMed ID: 15802932
[TBL] [Abstract][Full Text] [Related]
18. Comparison of features on SD-OCT between acute central serous chorioretinopathy and exudative age-related macular degeneration.
Ahn SJ; Kim TW; Huh JW; Yu HG; Chung H
Ophthalmic Surg Lasers Imaging; 2012; 43(5):374-82. PubMed ID: 22767337
[TBL] [Abstract][Full Text] [Related]
19. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.
Bousquet E; Beydoun T; Zhao M; Hassan L; Offret O; Behar-Cohen F
Retina; 2013; 33(10):2096-102. PubMed ID: 23719402
[TBL] [Abstract][Full Text] [Related]
20. Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy.
Shin YU; Lee BR
Am J Ophthalmol; 2012 Jul; 154(1):155-163.e4. PubMed ID: 22503695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]